Preauthorization Inconsistencies Prevail in Reduction Mammaplasty.

Area of Science:

• Plastic Surgery
• Health Services Research
• Insurance Policy Analysis

Background:

• Breast reduction (reduction mammaplasty) offers significant physical and psychological benefits.
• Obtaining approval from third-party payers for this procedure is often a complex and challenging process.
• Variability in insurance medical necessity criteria contributes to these difficulties.

Purpose of the Study:

• To analyze the differences in medical necessity criteria for reduction mammaplasty among major US insurance carriers.
• To investigate trends in insurance claim denials and appeals for this procedure.

Main Methods:

• Medical necessity criteria were collected from seven large US health insurance carriers.
• Data on claim requirements for approval were extracted from each policy.
• Prospective data on claims and denials from January to August 2022 were gathered from a medical consulting firm.

Main Results:

• Significant variation exists in insurance policies regarding required documentation (e.g., symptom duration, photographs) and tissue resection thresholds.
• 41.6% of 380 reduction mammaplasties faced initial insurance denial.
• Appeals revealed an average of 1.37 denials per patient, with 65.8% of initial denials being for preauthorized claims.

Conclusions:

• Disparities in medical necessity criteria among insurance carriers create practice inefficiencies.
• High denial and appeal rates delay essential surgical care for patients.
• Standardization of criteria could improve patient access and reduce administrative burden.